SG Americas Securities LLC Acquires 3,755 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX)

SG Americas Securities LLC boosted its holdings in MeiraGTx Holdings plc (NASDAQ:MGTX) by 30.8% in the fourth quarter, Holdings Channel reports. The firm owned 15,950 shares of the company’s stock after purchasing an additional 3,755 shares during the quarter. SG Americas Securities LLC’s holdings in MeiraGTx were worth $112,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in MGTX. Goldman Sachs Group Inc. raised its stake in shares of MeiraGTx by 631.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 299,678 shares of the company’s stock worth $4,150,000 after purchasing an additional 258,696 shares in the last quarter. Jefferies Financial Group Inc. acquired a new stake in MeiraGTx in the fourth quarter valued at $1,644,000. Renaissance Technologies LLC bought a new position in shares of MeiraGTx in the 2nd quarter valued at about $1,229,000. Dimensional Fund Advisors LP increased its stake in shares of MeiraGTx by 34.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 401,385 shares of the company’s stock worth $5,559,000 after purchasing an additional 103,686 shares during the last quarter. Finally, Alyeska Investment Group L.P. raised its holdings in shares of MeiraGTx by 43.4% in the 1st quarter. Alyeska Investment Group L.P. now owns 330,182 shares of the company’s stock valued at $1,707,000 after purchasing an additional 100,000 shares during the period. 67.48% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

MGTX has been the subject of a number of research analyst reports. TheStreet upgraded MeiraGTx from a “d” rating to a “c-” rating in a report on Friday, March 15th. Royal Bank of Canada reissued an “outperform” rating and set a $11.00 target price on shares of MeiraGTx in a report on Friday, March 15th.

MeiraGTx Stock Performance

Shares of MGTX stock opened at $5.09 on Friday. MeiraGTx Holdings plc has a 52 week low of $3.49 and a 52 week high of $8.35. The company has a market capitalization of $326.88 million, a price-to-earnings ratio of -3.46 and a beta of 1.29. The company has a 50-day simple moving average of $5.97 and a 200 day simple moving average of $5.64. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.38 and a current ratio of 2.38.

MeiraGTx (NASDAQ:MGTX) last issued its quarterly earnings data on Thursday, March 14th. The company reported ($0.47) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.01). MeiraGTx had a negative return on equity of 114.33% and a negative net margin of 599.47%. The firm had revenue of $2.04 million for the quarter, compared to the consensus estimate of $10.13 million. On average, sell-side analysts predict that MeiraGTx Holdings plc will post -1.4 earnings per share for the current year.

About MeiraGTx

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.